Preoperative erectile function is the only predictor of the use of a high number of phosphodiesterase type-5 inhibitors after bilateral nerve-sparing radical prostatectomy

G. Gandaglia, A. Gallina, N. Suardi, F. Abdollah, N. Passoni, M. Bianchi, E. Zaffuto, A. Nini, D. Vizziello, A. Salonia, F. Montorsi, A. Briganti

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

It is well known that the administration of phosphodiesterase type-5 inhibitors (PDE5-Is) may improve erectile function (EF) recovery after bilateral nerve-sparing radical prostatectomy (BNSRP). The aim of our study was to identify predictors of the use of a high number of PDE5-Is (one or more per week) after surgery among 184 patients taking proerectile medications on demand. At a mean follow-up of 22.7 months, 116 patients (63%) recovered EF. Overall, EF recovery rates at 1- and 2- year follow-up were 47.3% and 65.4%, respectively. Overall, 43 (23.4%) patients used one or more PDE5-Is per week. Preoperative EF was the only predictor of the use of one or more PDE5-Is per week after BNSRP. This held true even after adjusting our analyses for age at surgery, body mass index and EF at 1 month after surgery. Particularly, patients fully potent before surgery had roughly 2.1-fold higher probability of using one or more pills per week compared with their counterparts with some degree of preoperative erectile dysfunction (ED; odds ratio: 2.16; 95% confidence interval: 1.03-4.37). In conclusion, preoperative EF represents the only determinant of the use of a higher number of PDE5-Is after surgery. Patients with better preoperative EF might represent individuals more motivated to achieve satisfactory sexual function after surgery. These observations should provide physicians with better preoperative patient counseling and management of postoperative ED.

Original languageEnglish
Pages (from-to)201-204
Number of pages4
JournalInternational Journal of Impotence Research
Volume26
Issue number6
DOIs
Publication statusPublished - Nov 13 2014

Fingerprint

Phosphodiesterase 5 Inhibitors
Prostatectomy
Recovery of Function
Erectile Dysfunction
Counseling
Body Mass Index
Odds Ratio
Confidence Intervals
Physicians

ASJC Scopus subject areas

  • Urology
  • Medicine(all)

Cite this

Preoperative erectile function is the only predictor of the use of a high number of phosphodiesterase type-5 inhibitors after bilateral nerve-sparing radical prostatectomy. / Gandaglia, G.; Gallina, A.; Suardi, N.; Abdollah, F.; Passoni, N.; Bianchi, M.; Zaffuto, E.; Nini, A.; Vizziello, D.; Salonia, A.; Montorsi, F.; Briganti, A.

In: International Journal of Impotence Research, Vol. 26, No. 6, 13.11.2014, p. 201-204.

Research output: Contribution to journalArticle

@article{d5dd30610ffe4b1fae22ca224e648417,
title = "Preoperative erectile function is the only predictor of the use of a high number of phosphodiesterase type-5 inhibitors after bilateral nerve-sparing radical prostatectomy",
abstract = "It is well known that the administration of phosphodiesterase type-5 inhibitors (PDE5-Is) may improve erectile function (EF) recovery after bilateral nerve-sparing radical prostatectomy (BNSRP). The aim of our study was to identify predictors of the use of a high number of PDE5-Is (one or more per week) after surgery among 184 patients taking proerectile medications on demand. At a mean follow-up of 22.7 months, 116 patients (63{\%}) recovered EF. Overall, EF recovery rates at 1- and 2- year follow-up were 47.3{\%} and 65.4{\%}, respectively. Overall, 43 (23.4{\%}) patients used one or more PDE5-Is per week. Preoperative EF was the only predictor of the use of one or more PDE5-Is per week after BNSRP. This held true even after adjusting our analyses for age at surgery, body mass index and EF at 1 month after surgery. Particularly, patients fully potent before surgery had roughly 2.1-fold higher probability of using one or more pills per week compared with their counterparts with some degree of preoperative erectile dysfunction (ED; odds ratio: 2.16; 95{\%} confidence interval: 1.03-4.37). In conclusion, preoperative EF represents the only determinant of the use of a higher number of PDE5-Is after surgery. Patients with better preoperative EF might represent individuals more motivated to achieve satisfactory sexual function after surgery. These observations should provide physicians with better preoperative patient counseling and management of postoperative ED.",
author = "G. Gandaglia and A. Gallina and N. Suardi and F. Abdollah and N. Passoni and M. Bianchi and E. Zaffuto and A. Nini and D. Vizziello and A. Salonia and F. Montorsi and A. Briganti",
year = "2014",
month = "11",
day = "13",
doi = "10.1038/ijir.2014.10",
language = "English",
volume = "26",
pages = "201--204",
journal = "International Journal of Impotence Research",
issn = "0955-9930",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Preoperative erectile function is the only predictor of the use of a high number of phosphodiesterase type-5 inhibitors after bilateral nerve-sparing radical prostatectomy

AU - Gandaglia, G.

AU - Gallina, A.

AU - Suardi, N.

AU - Abdollah, F.

AU - Passoni, N.

AU - Bianchi, M.

AU - Zaffuto, E.

AU - Nini, A.

AU - Vizziello, D.

AU - Salonia, A.

AU - Montorsi, F.

AU - Briganti, A.

PY - 2014/11/13

Y1 - 2014/11/13

N2 - It is well known that the administration of phosphodiesterase type-5 inhibitors (PDE5-Is) may improve erectile function (EF) recovery after bilateral nerve-sparing radical prostatectomy (BNSRP). The aim of our study was to identify predictors of the use of a high number of PDE5-Is (one or more per week) after surgery among 184 patients taking proerectile medications on demand. At a mean follow-up of 22.7 months, 116 patients (63%) recovered EF. Overall, EF recovery rates at 1- and 2- year follow-up were 47.3% and 65.4%, respectively. Overall, 43 (23.4%) patients used one or more PDE5-Is per week. Preoperative EF was the only predictor of the use of one or more PDE5-Is per week after BNSRP. This held true even after adjusting our analyses for age at surgery, body mass index and EF at 1 month after surgery. Particularly, patients fully potent before surgery had roughly 2.1-fold higher probability of using one or more pills per week compared with their counterparts with some degree of preoperative erectile dysfunction (ED; odds ratio: 2.16; 95% confidence interval: 1.03-4.37). In conclusion, preoperative EF represents the only determinant of the use of a higher number of PDE5-Is after surgery. Patients with better preoperative EF might represent individuals more motivated to achieve satisfactory sexual function after surgery. These observations should provide physicians with better preoperative patient counseling and management of postoperative ED.

AB - It is well known that the administration of phosphodiesterase type-5 inhibitors (PDE5-Is) may improve erectile function (EF) recovery after bilateral nerve-sparing radical prostatectomy (BNSRP). The aim of our study was to identify predictors of the use of a high number of PDE5-Is (one or more per week) after surgery among 184 patients taking proerectile medications on demand. At a mean follow-up of 22.7 months, 116 patients (63%) recovered EF. Overall, EF recovery rates at 1- and 2- year follow-up were 47.3% and 65.4%, respectively. Overall, 43 (23.4%) patients used one or more PDE5-Is per week. Preoperative EF was the only predictor of the use of one or more PDE5-Is per week after BNSRP. This held true even after adjusting our analyses for age at surgery, body mass index and EF at 1 month after surgery. Particularly, patients fully potent before surgery had roughly 2.1-fold higher probability of using one or more pills per week compared with their counterparts with some degree of preoperative erectile dysfunction (ED; odds ratio: 2.16; 95% confidence interval: 1.03-4.37). In conclusion, preoperative EF represents the only determinant of the use of a higher number of PDE5-Is after surgery. Patients with better preoperative EF might represent individuals more motivated to achieve satisfactory sexual function after surgery. These observations should provide physicians with better preoperative patient counseling and management of postoperative ED.

UR - http://www.scopus.com/inward/record.url?scp=84909944071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84909944071&partnerID=8YFLogxK

U2 - 10.1038/ijir.2014.10

DO - 10.1038/ijir.2014.10

M3 - Article

VL - 26

SP - 201

EP - 204

JO - International Journal of Impotence Research

JF - International Journal of Impotence Research

SN - 0955-9930

IS - 6

ER -